The first Integra Lifesciences Holdings trade was made in Q2 2021.
Since then Ray Dalio bought shares eight more times and sold shares on six occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -29.5 Thousand shares
Q4 2024
Avg closing price
$21.88
Price range
$16.95
-
$26.70
Sold 73.9% shares (-83.8 Thousand shares)
Q3 2024
Avg closing price
$23.22
Price range
$17.14
-
$31.74
Increased shares by 70.1% (+46.7 Thousand shares)
Q2 2024
Avg closing price
$29.66
Price range
$23.14
-
$34.72
Sold 12.8% shares (-9.75 Thousand shares)
Q1 2024
Avg closing price
$40.00
Price range
$33.40
-
$45.20
Sold 13.4% shares (-11.8 Thousand shares)
Q4 2023
Avg closing price
$39.35
Price range
$34.21
-
$44.59
Increased shares by 7.6% (+6.26 Thousand shares)
Q3 2023
Avg closing price
$42.07
Price range
$37.80
-
$45.97
Sold 9.1% shares (-8.18 Thousand shares)
Q2 2023
Avg closing price
$48.13
Price range
$37.95
-
$58.98
Increased shares by 4.7% (+4.05 Thousand shares)
Q1 2023
Avg closing price
$56.35
Price range
$52.61
-
$60.49
Sold 25.5% shares (-29.5 Thousand shares)
Q4 2022
Avg closing price
$50.90
Price range
$41.79
-
$58.60
Increased shares by 0.4% (+424 shares)
Q3 2022
Avg closing price
$51.24
Price range
$42.28
-
$57.17
Increased shares by 10.4% (+10.8 Thousand shares)
Q2 2022
Avg closing price
$60.06
Price range
$53.86
-
$66.52
Increased shares by 28.8% (+23.3 Thousand shares)
Q1 2022
Avg closing price
$65.84
Price range
$62.86
-
$69.24
Increased shares by 8.0% (+6.02 Thousand shares)
Q4 2021
Avg closing price
$67.65
Price range
$62.47
-
$73.25
Increased shares by 7.3% (+5.08 Thousand shares)
Q3 2021